Skip to content

Evaluation of the efficacy of Chanqin Granules in the treatment of cough hypersensitivity syndrome

Evaluation of the efficacy of Chanqin Granules in the treatment of cough hypersensitivity syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070364
Enrollment
Unknown
Registered
2023-04-11
Start date
2023-03-27
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough Hypersensitivity Syndrome

Interventions

Chanqin Granule group:Chanqin Granule
Compound Methoxyphenamine Capsules group:Compound Methoxyphenamine Capsules

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Meet the western medicine diagnostic criteria of cough hypersensitivity syndrome. 2) Age is between 18 and 70 years old. 3) TCM syndrome differentiation belongs to the wind and evil bundle lung syndrome. 4) Do not smoke or quit smoking for more than 2 years. 5) Do not take angiotensin-converting enzyme inhibitors, opioids, pregabalin, and any drugs that may cause cough, including gabapentin. 6) Patient gave informed consent.

Exclusion criteria

Exclusion criteria: 1) People with other chronic respiratory diseases, such as pulmonary interstitial fibrosis, chronic bronchitis, emphysema, pulmonary heart disease, chronic obstructive pulmonary disease, lung cancer, tuberculosis, respiratory failure, etc., or people infected with the lower respiratory tract; 2) The etiology of chronic cough has been clearly diagnosed: including upper airway cough syndrome, eosinophilic bronchitis, allergic cough, cough variant asthma, gastroesophageal reflux syndrome, drug reaction, pulmonary infection, pulmonary and tracheal intimal tuberculosis, adult pertussis, etc.; 3) Pregnant or lactating women, or women preparing for pregnancy. 4) Allergy to the drug ingredients used. 5) Patients with mental illness, or poor compliance, who are not worthy of the test. 6) Diagnosis of patients with severe primary diseases such as heart, liver, kidney and hematopoietic system.

Design outcomes

Primary

MeasureTime frame
cough;

Secondary

MeasureTime frame
Mandarin Chinese version of the Leicester Cough Questionnaire;Hull Airway Reflux Questionnaire;Traditional Chinese Medicine Syndrome Points;SAS Anxiety Self Rating Scale;AIR Respiratory Anxiety Scale;

Countries

China

Contacts

Public ContactShen Ruobing

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

shen-robin@126.com13817722029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026